SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-012523
Filing Date
2022-08-08
Accepted
2022-08-08 08:00:39
Documents
51
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q qure-20220630x10q.htm   iXBRL 10-Q 2046026
2 EX-31.1 qure-20220630xex31d1.htm EX-31.1 15056
3 EX-31.2 qure-20220630xex31d2.htm EX-31.2 15060
4 EX-32.1 qure-20220630xex32d1.htm EX-32.1 14743
  Complete submission text file 0001558370-22-012523.txt   6906830

Data Files

Seq Description Document Type Size
5 EX-101.SCH qure-20220630.xsd EX-101.SCH 35989
6 EX-101.CAL qure-20220630_cal.xml EX-101.CAL 45201
7 EX-101.DEF qure-20220630_def.xml EX-101.DEF 227114
8 EX-101.LAB qure-20220630_lab.xml EX-101.LAB 405783
9 EX-101.PRE qure-20220630_pre.xml EX-101.PRE 312685
45 EXTRACTED XBRL INSTANCE DOCUMENT qure-20220630x10q_htm.xml XML 1143262
Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP 1-339-970-7000
uniQure N.V. (Filer) CIK: 0001590560 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36294 | Film No.: 221142602
SIC: 2834 Pharmaceutical Preparations